Pathfinder Cell Therapy PFND Stock
Pathfinder Cell Therapy Price Chart
Pathfinder Cell Therapy PFND Financial and Trading Overview
| Pathfinder Cell Therapy stock price | 0.0001 USD |
| Previous Close | 1.0E-6 USD |
| Open | 1.0E-6 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 1.0E-6 - 1.0E-6 USD |
| 52 Week Range | 1.0E-6 - 0.0001 USD |
| Volume | 800 USD |
| Avg. Volume | 0 USD |
| Market Cap | 20.01K USD |
| Beta (5Y Monthly) | -20.085915 |
| PE Ratio (TTM) | Infinity |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PFND Valuation Measures
| Enterprise Value | 5.41M USD |
| Trailing P/E | Infinity |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -7.007 |
Trading Information
Pathfinder Cell Therapy Stock Price History
| Beta (5Y Monthly) | -20.085915 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.0001 USD |
| 52 Week Low | 1.0E-6 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 8.65E-5 USD |
PFND Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 667.16M |
| Float | N/A |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2014 |
| Most Recent Quarter (mrq) | September 30, 2015 |
| Next Fiscal Year End | December 31, 2015 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -888.76% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -772000 USD |
| Net Income Avi to Common (ttm) | -1080000 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 5.41M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.001 |
| Book Value Per Share (mrq) | -0.01 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -579000 USD |
| Levered Free Cash Flow (ttm) | -223000 USD |
Profile of Pathfinder Cell Therapy
| Country | United States |
| State | MA |
| City | Cambridge |
| Address | 12 Bow Street |
| ZIP | 02138 |
| Phone | 617-245-0289 |
| Website | https://www.pathfindercelltherapy.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 1 |
Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies based on its technology. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts.
Q&A For Pathfinder Cell Therapy Stock
What is a current PFND stock price?
Pathfinder Cell Therapy PFND stock price today per share is 0.0001 USD.
How to purchase Pathfinder Cell Therapy stock?
You can buy PFND shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Pathfinder Cell Therapy?
The stock symbol or ticker of Pathfinder Cell Therapy is PFND.
Which industry does the Pathfinder Cell Therapy company belong to?
The Pathfinder Cell Therapy industry is Biotechnology.
How many shares does Pathfinder Cell Therapy have in circulation?
The max supply of Pathfinder Cell Therapy shares is 20.01B.
What is Pathfinder Cell Therapy Price to Earnings Ratio (PE Ratio)?
Pathfinder Cell Therapy PE Ratio is now.
What was Pathfinder Cell Therapy earnings per share over the trailing 12 months (TTM)?
Pathfinder Cell Therapy EPS is 0 USD over the trailing 12 months.
Which sector does the Pathfinder Cell Therapy company belong to?
The Pathfinder Cell Therapy sector is Healthcare.